58650-48-9Relevant articles and documents
GLUCAGON RECEPTOR MODULATORS
-
Page/Page column 35, (2012/08/27)
The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, A1, A2, A3, A4, L, B1, B2, B3 and B4 are as defined herein. The compounds of Formula I have been found to act as glucagon antagonists or inverse agonists. Consequently, the compounds of Formula I and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucagon.
Concentration and basicity of histamine rotamers
Kraszni, Marta,Koekoesi, Jozsef,Noszal, Bela
, p. 914 - 917 (2007/10/03)
A method was developed and applied to determine the populations and site- and conformer-specific basicities of histamine rotamers in three distinct states of protonation. The method that has been developed also allows the determination of molecule- and po
Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
-
, (2008/06/13)
Novel imidazole compounds are disclosed, which are represented by the following general formula: STR1 wherein: R1 represents a cyano group or a --CSNHR5 group, wherein R5 represents a hydrogen atom, a C1-4 alkyl group, or a --COR6 group, wherein R6 represents a C1-4 alkyl group, a halogenated C1-4 alkyl group, or a phenyl group; R2 and R3 each represents a hydrogen atom; a halogen atom; a nitro group; a cyano group; a trimethylsilyl group; a C3-6 cycloalkyl group; a naphthyl group; a C1-12 alkyl group which is optionally substituted with one or more halogen atoms, hydroxyl groups, acetoxy groups, C1-4 alkoxy groups, halogenated C1-4 alkoxy groups, phenyl groups, halogenated phenyl groups, or C1-4 alkylated phenyl groups; a C2-10 alkenyl group which is optionally substituted with one or more halogen atoms; a C1-6 alkoxy group which is optionally substituted with one or more halogen atoms; a phenyl group which is optionally substituted with one or more halogen atoms, C1-4 alkyl groups, halogenated C1-4 alkyl groups, C1-4 alkoxy groups, halogenated C1-4 alkoxy groups, C1-4 alkylthio groups, halogenated C1-4 alkylthio groups, nitro groups, cyano groups, or 3,4-methylenedioxy groups; a furyl group which is optionally substituted with one or more halogen atoms or C1-4 alkyl groups; a thienyl group which is optionally substituted with one or more halogen atoms or C1-4 alkyl groups; a pyridyl group which is optionally substituted with one or more halogen atoms or C1-4 alkyl groups; an --SOn R7 group, wherein R7 represents a C1-6 alkyl group, a C2-6 alkenyl group, a phenyl group which is optionally substituted with one or more halogen atoms, a benzyl group, a pyridyl group which is optionally substituted with one or more halogen atoms, C1-4 alkyl groups, or halogenated C1-4 alkyl groups; or an --NR8 R9 group, wherein R8 and R9 each represents a C1-4 alkyl group, and n is 0, 1, or 2; or a --CO(NH)m R10 group, wherein R10 represents a C1-4 alkyl group which is optionally substituted with one or more halogen atoms, a C1-4 alkoxy group which is optionally substituted with one or more halogen atoms, or a phenyl group which is optionally substituted with one or more halogen atoms; and m is 0 or 1; and R4 represents a C1-6 alkyl group which is optionally substituted with one or more halogen atoms; a C3-6 cycloalkyl group; a phenyl group; a thienyl group; or an --NR11 R12 group, wherein R11 and R12 each represents a hydrogen atom, a C1-4 alkyl group which is optionally substituted with one or more halogen atoms, a C2-4 alkenyl group, or R11 and R12 are combined with each other together with a nitrogen atoms adjacent thereto to form a pyrrolidinyl group, a piperidinyl group, a morpholino group, or a thiomorpholino group, provided that R11 and R12 are not simultaneously a hydrogen atom; provided that R2 and R3 are not simultaneously a halogen atom. The compounds are effective as biocides.